{"transactions":[{"id":1371818,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-11-08T23:21:45.000Z","date":"2024-11-07","kind":"gift","planned":false,"acquired":false,"shares":470,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 965 shares held by the reporting person to William D. Barbo Revocable Trust."}],"balance_after":23337,"source":{"system":"sec-edgar","filing":"0001127602-24-026871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224026871/form4.xml","form_type":"4"}},{"id":1498276,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-31T00:05:08.000Z","date":"2024-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":179,"price":214.51,"value":38397.29,"ownership":{"direct":true},"balance_after":3433,"source":{"system":"sec-edgar","filing":"0001127602-24-017059","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017059/form4.xml","form_type":"4"}},{"id":1498270,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-30T23:47:27.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":99,"price":217.21,"value":21503.79,"ownership":{"direct":true},"balance_after":3612,"source":{"system":"sec-edgar","filing":"0001127602-24-017041","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017041/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-28"}},{"id":1498269,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-30T23:47:27.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":147,"price":217.21,"value":31929.87,"ownership":{"direct":true},"balance_after":3711,"source":{"system":"sec-edgar","filing":"0001127602-24-017041","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017041/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-28"}},{"id":1498268,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-30T23:47:27.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":177,"price":217.21,"value":38446.17,"ownership":{"direct":true},"balance_after":3858,"source":{"system":"sec-edgar","filing":"0001127602-24-017041","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224017041/form4a.xml","form_type":"4/A","original_submission_date":"2024-05-28"}},{"id":1500833,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-28T21:42:40.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":84,"price":217.21,"value":18245.64,"ownership":{"direct":true},"balance_after":3605,"source":{"system":"sec-edgar","filing":"0001127602-24-016732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016732/form4.xml","form_type":"4"}},{"id":1500832,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-28T21:42:40.000Z","date":"2024-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":132,"price":217.21,"value":28671.72,"ownership":{"direct":true},"balance_after":3689,"source":{"system":"sec-edgar","filing":"0001127602-24-016732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016732/form4.xml","form_type":"4"}},{"id":1500831,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-05-28T21:42:40.000Z","date":"2024-05-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":177,"price":217.21,"value":38446.17,"ownership":{"direct":true},"balance_after":3821,"source":{"system":"sec-edgar","filing":"0001127602-24-016732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224016732/form4.xml","form_type":"4"}},{"id":1562170,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-03-25T22:48:26.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":744,"price":220.28,"value":163888.32,"ownership":{"direct":true},"balance_after":11293,"source":{"system":"sec-edgar","filing":"0001127602-24-011121","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011121/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1562169,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-03-25T22:48:26.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":2934,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":12037,"source":{"system":"sec-edgar","filing":"0001127602-24-011121","document":"form4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224011121/form4a.xml","form_type":"4/A","original_submission_date":"2024-01-31"}},{"id":1623035,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-02-23T21:57:40.000Z","date":"2024-02-22","kind":"sale","planned":false,"acquired":false,"shares":4050,"price":248.5,"value":1006425.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reflects the exempt transfer pursuant to Rule 16a-13 of 7,547 shares held by the reporting person to William D. Barbo Revocable Trust."}],"balance_after":22879,"source":{"system":"sec-edgar","filing":"0001127602-24-006706","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224006706/form4.xml","form_type":"4"}},{"id":1665537,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-01-31T22:23:02.000Z","date":"2024-01-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":770,"price":220.28,"value":169615.6,"ownership":{"direct":true},"balance_after":11330,"source":{"system":"sec-edgar","filing":"0001127602-24-002794","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002794/form4.xml","form_type":"4"}},{"id":1665536,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2024-01-31T22:23:02.000Z","date":"2024-01-29","kind":"grant","planned":false,"acquired":true,"shares":2997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 28, 2021."}],"balance_after":12100,"source":{"system":"sec-edgar","filing":"0001127602-24-002794","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760224002794/form4.xml","form_type":"4"}},{"id":1808883,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-08-14T20:17:54.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":false,"shares":5511,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":5511},"source":{"system":"sec-edgar","filing":"0001127602-23-022488","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223022488/form4.xml","form_type":"4"}},{"id":1808882,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-08-14T20:17:54.000Z","date":"2023-08-10","kind":"exercise","planned":false,"acquired":true,"shares":5511,"price":144.67,"value":797276.37,"ownership":{"direct":true},"balance_after":9103,"source":{"system":"sec-edgar","filing":"0001127602-23-022488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223022488/form4.xml","form_type":"4"}},{"id":1808881,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-08-14T20:17:54.000Z","date":"2023-08-10","kind":"sale","planned":false,"acquired":false,"shares":5763,"price":217.24,"value":1251954.12,"ownership":{"direct":true},"balance_after":3592,"source":{"system":"sec-edgar","filing":"0001127602-23-022488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223022488/form4.xml","form_type":"4"}},{"id":1873619,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-31T17:27:20.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":4696,"price":194.12,"value":911587.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,174 on May 26, 2024, 1,174 on May 26, 2025, 1,174 on May 26, 2026 and 1,174 on May 26, 2027."}],"balance_after":4696,"derivative":{"exercise_price":194.12,"exercise_date":"2024-05-26","expiration_date":"2033-05-26","underlying":"Common Stock","underlying_shares":4696},"source":{"system":"sec-edgar","filing":"0001127602-23-017135","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017135/form4.xml","form_type":"4"}},{"id":1873618,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-05-31T17:27:20.000Z","date":"2023-05-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":202,"price":194.12,"value":39212.24,"ownership":{"direct":true},"balance_after":9954,"source":{"system":"sec-edgar","filing":"0001127602-23-017135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017135/form4.xml","form_type":"4"}},{"id":1873617,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-05-31T17:27:20.000Z","date":"2023-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":112,"price":194.12,"value":21741.44,"ownership":{"direct":true},"balance_after":10156,"source":{"system":"sec-edgar","filing":"0001127602-23-017135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017135/form4.xml","form_type":"4"}},{"id":1873616,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-05-31T17:27:20.000Z","date":"2023-05-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":166,"price":194.12,"value":32223.92,"ownership":{"direct":true},"balance_after":10268,"source":{"system":"sec-edgar","filing":"0001127602-23-017135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017135/form4.xml","form_type":"4"}},{"id":1873615,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-05-31T17:27:20.000Z","date":"2023-05-26","kind":"grant","planned":false,"acquired":true,"shares":1958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units vest as follows: 489 on May 26, 2024, 489 on May 26, 2025, 490 on May 26, 2026 and 490 on May 26, 2027."}],"balance_after":10434,"source":{"system":"sec-edgar","filing":"0001127602-23-017135","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223017135/form4.xml","form_type":"4"}},{"id":2000513,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-02-22T21:29:21.000Z","date":"2023-02-22","kind":"tax_withholding","acquired":false,"shares":287,"price":243.6,"value":69913.2,"ownership":{"direct":true},"balance_after":8476,"source":{"system":"sec-edgar","filing":"0001127602-23-006469","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223006469/form4.xml","form_type":"4"}},{"id":2042497,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-01-30T21:48:56.000Z","date":"2023-01-27","kind":"tax_withholding","acquired":false,"shares":2897,"price":244.29,"value":707708.13,"ownership":{"direct":true},"balance_after":8763,"source":{"system":"sec-edgar","filing":"0001127602-23-002678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002678/form4.xml","form_type":"4"}},{"id":2042496,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2023-01-30T21:48:56.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":7857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on May 29, 2020."}],"balance_after":11660,"source":{"system":"sec-edgar","filing":"0001127602-23-002678","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760223002678/form4.xml","form_type":"4"}},{"id":2094809,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":3205},"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094808,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":700,"price":221.0761,"value":154753.27,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $220.93 to $221.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3803,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094807,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":1226,"price":220.1399,"value":269891.5174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $219.90 to $220.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4503,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094806,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":873,"price":219.4141,"value":191548.5093,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $218.92 to $219.83. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5729,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094805,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":406,"price":218.2778,"value":88620.7868,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $217.89 to $218.875. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":6602,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094804,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":3205,"price":109.34,"value":350434.7,"ownership":{"direct":true},"balance_after":7008,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094803,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-11-15","kind":"gift","acquired":false,"shares":200,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":19035,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094802,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-06-07","kind":"gift","acquired":true,"shares":391,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":19235,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2094801,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-12-06T21:40:40.000Z","date":"2022-06-07","kind":"gift","acquired":false,"shares":391,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3803,"source":{"system":"sec-edgar","filing":"0000950103-22-020817","document":"dp185494_4-barbo.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000095010322020817/dp185494_4-barbo.xml","form_type":"4"}},{"id":2249842,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-06-01T21:14:11.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":4036,"price":244.41,"value":986438.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,009 on May 27, 2023, 1,009 on May 27, 2024, 1,009 on May 27, 2025 and 1,009 on May 27, 2026."}],"balance_after":4036,"derivative":{"exercise_price":244.41,"exercise_date":"2023-05-27","expiration_date":"2032-05-27","underlying":"Common Stock","underlying_shares":4036},"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2249841,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-06-01T21:14:11.000Z","date":"2022-05-29","kind":"tax_withholding","acquired":false,"shares":202,"price":244.41,"value":49370.82,"ownership":{"direct":true},"balance_after":4194,"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2249840,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-06-01T21:14:11.000Z","date":"2022-05-28","kind":"tax_withholding","acquired":false,"shares":112,"price":244.41,"value":27373.92,"ownership":{"direct":true},"balance_after":4396,"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2249839,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-06-01T21:14:11.000Z","date":"2022-05-27","kind":"grant","acquired":true,"shares":1493,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 373 on May 27, 2023, 373 on May 27, 2024, 373 on May 27, 2025 and 374 on May 27, 2026."}],"balance_after":4508,"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2249838,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-06-01T21:14:11.000Z","date":"2022-03-11","kind":"gift","acquired":true,"shares":754,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":18844,"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2249837,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-06-01T21:14:11.000Z","date":"2022-03-11","kind":"gift","acquired":false,"shares":754,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3015,"source":{"system":"sec-edgar","filing":"0001127602-22-016208","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222016208/form4.xml","form_type":"4"}},{"id":2379293,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-23T21:13:23.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":289.58,"value":91217.7,"ownership":{"direct":true},"balance_after":3769,"source":{"system":"sec-edgar","filing":"0001127602-22-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006261/form4.xml","form_type":"4"}},{"id":2379292,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-23T21:13:23.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":287,"price":293.61,"value":84266.07,"ownership":{"direct":true},"balance_after":4084,"source":{"system":"sec-edgar","filing":"0001127602-22-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006261/form4.xml","form_type":"4"}},{"id":2379291,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-23T21:13:23.000Z","date":"2022-02-08","kind":"gift","acquired":true,"shares":6178,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":18090,"source":{"system":"sec-edgar","filing":"0001127602-22-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006261/form4.xml","form_type":"4"}},{"id":2379290,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-23T21:13:23.000Z","date":"2022-02-08","kind":"gift","acquired":false,"shares":6178,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4371,"source":{"system":"sec-edgar","filing":"0001127602-22-006261","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222006261/form4.xml","form_type":"4"}},{"id":2419642,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-01T22:35:44.000Z","date":"2022-01-28","kind":"tax_withholding","acquired":false,"shares":4095,"price":312.24,"value":1278622.8,"ownership":{"direct":true},"balance_after":10549,"source":{"system":"sec-edgar","filing":"0001127602-22-002797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002797/form4.xml","form_type":"4"}},{"id":2419641,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-01T22:35:44.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":10273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 22, 2019."}],"balance_after":14644,"source":{"system":"sec-edgar","filing":"0001127602-22-002797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002797/form4.xml","form_type":"4"}},{"id":2419640,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2022-02-01T22:35:44.000Z","date":"2021-12-01","kind":"gift","acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11912,"source":{"system":"sec-edgar","filing":"0001127602-22-002797","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760222002797/form4.xml","form_type":"4"}},{"id":2608843,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":1513,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4541,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":1513},"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608842,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":2755,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5511,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":2755},"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608841,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":false,"shares":3204,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3205,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":3204},"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608840,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":200,"price":409.08,"value":81816.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":4371,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608839,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":500,"price":407.448,"value":203724.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This transaction was executed in multiple trades at prices ranging from $407.28 to $407.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":4571,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608838,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":7,"price":406.52,"value":2845.64,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":5071,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608837,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":1685,"price":405.5777,"value":683398.4245,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $405.20 to $406.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":5078,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608836,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":692,"price":404.8181,"value":280134.1252,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $404.16 to $405.005. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":6763,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608835,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":726,"price":403.5978,"value":293012.0028,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $403.175 to $403.915. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":7455,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608834,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":2380,"price":402.6442,"value":958293.196,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $402.26 to $403.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":8181,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608833,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":3253,"price":401.6241,"value":1306483.1973,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $401.15 to $402.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":10561,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608832,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"sale","acquired":false,"shares":2944,"price":400.8305,"value":1180044.992,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $400.15 to $401.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":13814,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608831,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":1513,"price":179.66,"value":271825.58,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":16758,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608830,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":2755,"price":144.67,"value":398565.85,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":15245,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608829,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-08-06","kind":"exercise","acquired":true,"shares":3204,"price":109.34,"value":350325.36,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":12490,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608828,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-06-09","kind":"gift","acquired":true,"shares":252,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"4,915 shares were transferred from Trust to Direct Holdings."}],"balance_after":12312,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2608827,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-08-10T15:52:31.000Z","date":"2021-06-09","kind":"gift","acquired":false,"shares":252,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4371,"source":{"system":"sec-edgar","filing":"0001127602-21-023431","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221023431/form4.xml","form_type":"4"}},{"id":2689433,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-06-01T21:53:40.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":3110,"price":337.99,"value":1051148.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 777 on May 28, 2022, 778 on May 28, 2023, 777 on May 28, 2024 and 778 on May 28, 2025."}],"balance_after":3110,"derivative":{"exercise_price":337.99,"exercise_date":"2022-05-28","expiration_date":"2031-05-28","underlying":"Common Stock","underlying_shares":3110},"source":{"system":"sec-edgar","filing":"0001127602-21-018558","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018558/form4.xml","form_type":"4"}},{"id":2689432,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-06-01T21:53:40.000Z","date":"2021-05-29","kind":"tax_withholding","acquired":false,"shares":201,"price":337.99,"value":67935.99,"ownership":{"direct":true},"balance_after":4623,"source":{"system":"sec-edgar","filing":"0001127602-21-018558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018558/form4.xml","form_type":"4"}},{"id":2689431,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-06-01T21:53:40.000Z","date":"2021-05-28","kind":"grant","acquired":true,"shares":1006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 251 on May 28, 2022, 252 on May 28, 2023, 251 on May 28, 2024 and 252 on May 28, 2025."}],"balance_after":4824,"source":{"system":"sec-edgar","filing":"0001127602-21-018558","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221018558/form4.xml","form_type":"4"}},{"id":2821495,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-03-02T21:37:29.000Z","date":"2021-03-01","kind":"exercise","acquired":false,"shares":3493,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":3493},"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2821494,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:37:29.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":1157,"price":290.4306,"value":336028.2042,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $290.428 to $290.50. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16975,"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2821493,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:37:29.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":3493,"price":290.0978,"value":1013311.6154,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $290.00 to $290.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3818,"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2821492,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:37:29.000Z","date":"2021-03-01","kind":"exercise","acquired":true,"shares":3493,"price":88.05,"value":307558.65,"ownership":{"direct":true},"balance_after":7311,"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2821491,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:37:29.000Z","date":"2021-02-25","kind":"gift","acquired":true,"shares":1157,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":18132,"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2821490,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-03-02T21:37:29.000Z","date":"2021-02-25","kind":"gift","acquired":false,"shares":1157,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3818,"source":{"system":"sec-edgar","filing":"0001127602-21-008726","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221008726/form4.xml","form_type":"4"}},{"id":2833301,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-25T21:14:28.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":322,"price":282.98,"value":91119.56,"ownership":{"direct":true},"balance_after":4975,"source":{"system":"sec-edgar","filing":"0001127602-21-007883","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007883/form4.xml","form_type":"4"}},{"id":2836378,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-24T16:35:08.000Z","date":"2021-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":283.59,"value":89330.85,"ownership":{"direct":true},"balance_after":5297,"source":{"system":"sec-edgar","filing":"0001127602-21-007536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007536/form4.xml","form_type":"4"}},{"id":2836377,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-24T16:35:08.000Z","date":"2021-02-22","kind":"tax_withholding","acquired":false,"shares":287,"price":289.55,"value":83100.85,"ownership":{"direct":true},"balance_after":5612,"source":{"system":"sec-edgar","filing":"0001127602-21-007536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007536/form4.xml","form_type":"4"}},{"id":2836376,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-24T16:35:08.000Z","date":"2021-02-04","kind":"gift","acquired":true,"shares":7154,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":16975,"source":{"system":"sec-edgar","filing":"0001127602-21-007536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007536/form4.xml","form_type":"4"}},{"id":2836375,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-24T16:35:08.000Z","date":"2021-02-04","kind":"gift","acquired":false,"shares":7154,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5899,"source":{"system":"sec-edgar","filing":"0001127602-21-007536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221007536/form4.xml","form_type":"4"}},{"id":2886393,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-02T15:48:36.000Z","date":"2021-02-02","kind":"tax_withholding","acquired":false,"shares":4708,"price":260.88,"value":1228223.04,"ownership":{"direct":true},"balance_after":13053,"source":{"system":"sec-edgar","filing":"0001127602-21-003419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003419/form4.xml","form_type":"4"}},{"id":2886392,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2021-02-02T15:48:36.000Z","date":"2021-02-02","kind":"grant","acquired":true,"shares":11862,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares of common stock issued following the achievement of performance goals set forth in performance share unit awards originally granted on February 23, 2018."}],"balance_after":17761,"source":{"system":"sec-edgar","filing":"0001127602-21-003419","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760221003419/form4.xml","form_type":"4"}},{"id":2991330,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-11-05T20:51:07.000Z","date":"2020-11-03","kind":"sale","acquired":false,"shares":2150,"price":236.2861,"value":508015.115,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $236.267 to $236.361. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9821,"source":{"system":"sec-edgar","filing":"0001127602-20-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028232/form4.xml","form_type":"4"}},{"id":2991329,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-11-05T20:51:07.000Z","date":"2020-10-30","kind":"gift","acquired":false,"shares":180,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11971,"source":{"system":"sec-edgar","filing":"0001127602-20-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028232/form4.xml","form_type":"4"}},{"id":2991328,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-11-05T20:51:07.000Z","date":"2020-03-23","kind":"gift","acquired":true,"shares":12151,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":12151,"source":{"system":"sec-edgar","filing":"0001127602-20-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028232/form4.xml","form_type":"4"}},{"id":2991327,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-11-05T20:51:07.000Z","date":"2020-03-23","kind":"gift","acquired":false,"shares":12151,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5899,"source":{"system":"sec-edgar","filing":"0001127602-20-028232","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220028232/form4.xml","form_type":"4"}},{"id":3127562,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-06-02T18:10:41.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":6054,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Stock Options vest as follows: 1,513 on May 29, 2021, 1,514 on May 29, 2022, 1,513 on May 29, 2023 and 1,514 on May 29, 2024."}],"balance_after":6054,"derivative":{"exercise_price":179.66,"exercise_date":"2021-05-29","expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":6054},"source":{"system":"sec-edgar","filing":"0001127602-20-018384","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220018384/form4.xml","form_type":"4"}},{"id":3127561,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-06-02T18:10:41.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":1815,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Unvested restricted stock units vest as follows: 453 on May 29, 2021, 454 on May 29, 2022, 454 on May 29, 2023 and 454 on May 29, 2024."}],"balance_after":18050,"source":{"system":"sec-edgar","filing":"0001127602-20-018384","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220018384/form4.xml","form_type":"4"}},{"id":3223011,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":2755,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8266,"derivative":{"exercise_price":144.67,"exercise_date":"2020-02-22","expiration_date":"2024-02-22","underlying":"Common Stock","underlying_shares":2755},"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223010,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":3205,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6409,"derivative":{"exercise_price":109.34,"exercise_date":"2019-02-23","expiration_date":"2023-02-23","underlying":"Common Stock","underlying_shares":3205},"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223009,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":3492,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3493,"derivative":{"exercise_price":88.05,"exercise_date":"2018-02-24","expiration_date":"2022-02-24","underlying":"Common Stock","underlying_shares":3492},"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223008,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":false,"shares":3015,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":73.7,"exercise_date":"2017-02-26","expiration_date":"2021-02-26","underlying":"Common Stock","underlying_shares":3015},"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223007,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":5005,"price":164.8055,"value":824851.5275,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $164.59 to $165.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":16235,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223006,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"sale","acquired":false,"shares":8961,"price":164.0942,"value":1470448.1262,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $163.56 to $164.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":21240,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223005,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":2755,"price":144.67,"value":398565.85,"ownership":{"direct":true},"balance_after":30201,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223004,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":3205,"price":109.34,"value":350434.7,"ownership":{"direct":true},"balance_after":27446,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223003,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":3492,"price":88.05,"value":307470.6,"ownership":{"direct":true},"balance_after":24241,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3223002,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-03-06T20:50:13.000Z","date":"2020-03-05","kind":"exercise","acquired":true,"shares":3015,"price":73.7,"value":222205.5,"ownership":{"direct":true},"balance_after":20749,"source":{"system":"sec-edgar","filing":"0001127602-20-009777","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220009777/form4.xml","form_type":"4"}},{"id":3246720,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-02-26T17:31:03.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":273,"price":162.46,"value":44351.58,"ownership":{"direct":true},"balance_after":17734,"source":{"system":"sec-edgar","filing":"0001127602-20-007871","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220007871/form4.xml","form_type":"4"}},{"id":3253588,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-02-24T17:40:27.000Z","date":"2020-02-24","kind":"tax_withholding","acquired":false,"shares":322,"price":173.64,"value":55912.08,"ownership":{"direct":true},"balance_after":18007,"source":{"system":"sec-edgar","filing":"0001127602-20-007134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220007134/form4.xml","form_type":"4"}},{"id":3253587,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-02-24T17:40:27.000Z","date":"2020-02-23","kind":"tax_withholding","acquired":false,"shares":315,"price":173.64,"value":54696.6,"ownership":{"direct":true},"balance_after":18329,"source":{"system":"sec-edgar","filing":"0001127602-20-007134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220007134/form4.xml","form_type":"4"}},{"id":3253586,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-02-24T17:40:27.000Z","date":"2020-02-22","kind":"tax_withholding","acquired":false,"shares":287,"price":173.64,"value":49834.68,"ownership":{"direct":true},"balance_after":18644,"source":{"system":"sec-edgar","filing":"0001127602-20-007134","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220007134/form4.xml","form_type":"4"}},{"id":3271296,"issuer":{"id":3398,"kind":"organization","name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","symbol":"CRL"},"owners":[{"id":86232,"kind":"person","name":"Barbo William D","position":1,"cik":"0001688104","reported_name":"Barbo William D","relationship":{"officer":true,"officer_title":"Corporate Executive VP & CCO"}}],"security":"Common Stock","published_at":"2020-02-14T17:01:21.000Z","date":"2020-02-13","kind":"sale","acquired":false,"shares":6901,"price":172.1053,"value":1187698.6753,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $171.94 to $172.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":18931,"source":{"system":"sec-edgar","filing":"0001127602-20-005459","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1100682/000112760220005459/form4.xml","form_type":"4"}}],"next_cursor":"2020-02-14T17:01:21.000000Z,3271296"}